Literature DB >> 17954700

Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains.

Maria Luisa Mangoni1, Giuseppantonio Maisetta, Mariagrazia Di Luca, Ludovica Marcellini Hercolani Gaddi, Semih Esin, Walter Florio, Franca Lisa Brancatisano, Donatella Barra, Mario Campa, Giovanna Batoni.   

Abstract

Due to the widespread resistance of bacteria to the available drugs, the discovery of new classes of antibiotics is urgently needed, and naturally occurring antimicrobial peptides (AMPs) are considered promising candidates for future therapeutic use. Amphibian skin is one of the richest sources of such AMPs. In the present study we compared the in vitro bactericidal activities of five AMPs from three different species of anurans against multidrug-resistant clinical isolates belonging to species often involved in nosocomial infections (Staphylococcus aureus, Enterococcus faecium, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Acinetobacter baumannii). The peptides tested were temporins A, B, and G from Rana temporaria; the fragment from positions 1 to 18 of esculentin 1b [Esc(1-18)] from Rana esculenta; and bombinin H2 from Bombina variegata. When they were tested in buffer, all the peptides were bactericidal against all bacterial species tested (three strains of each species) at concentrations ranging from 0.5 to 48 microM, with only a few exceptions. The temporins were found to be more active against gram-positive bacteria, especially when they were assayed in human serum; Esc(1-18) showed fast and strong bactericidal activity, within 2 to 20 min, especially against the gram-negative species, which were killed by Esc(1-18) at concentrations ranging from 0.5 to 1 microM; bombinin H2 displayed similar bactericidal activity toward all isolates. Interestingly, while the activities of the temporins and bombinin H2 were almost completely inhibited in the presence of 20% human serum, the activity of Esc(1-18) against the gram-negative species was partially preserved in the presence of 40% serum. This property renders this peptide an attractive molecule for use in the development of new compounds for the treatment of infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954700      PMCID: PMC2223874          DOI: 10.1128/AAC.00796-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

Review 1.  Antimicrobial peptides: premises and promises.

Authors:  K V R Reddy; R D Yedery; C Aranha
Journal:  Int J Antimicrob Agents       Date:  2004-12       Impact factor: 5.283

2.  In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains.

Authors:  Giuseppantonio Maisetta; Giovanna Batoni; Semih Esin; Walter Florio; Daria Bottai; Flavia Favilli; Mario Campa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Resistance to anti-infective drugs and the threat to public health.

Authors:  David L Heymann
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

4.  Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.

Authors:  Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Wojciech Kamysz; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Jerzy Łukasiak; Vittorio Saba; Giorgio Scalise
Journal:  J Infect Dis       Date:  2005-09-27       Impact factor: 5.226

Review 5.  Resistance to antibiotics: are we in the post-antibiotic era?

Authors:  Alfonso J Alanis
Journal:  Arch Med Res       Date:  2005 Nov-Dec       Impact factor: 2.235

Review 6.  Peptides as weapons against microorganisms in the chemical defense system of vertebrates.

Authors:  P Nicolas; A Mor
Journal:  Annu Rev Microbiol       Date:  1995       Impact factor: 15.500

7.  Comparison of synthesis and antibacterial activity of temporin A.

Authors:  I Harjunpää; P Kuusela; M T Smoluch; J Silberring; H Lankinen; D Wade
Journal:  FEBS Lett       Date:  1999-04-23       Impact factor: 4.124

8.  Temporins, antimicrobial peptides from the European red frog Rana temporaria.

Authors:  M Simmaco; G Mignogna; S Canofeni; R Miele; M L Mangoni; D Barra
Journal:  Eur J Biochem       Date:  1996-12-15

9.  Antimicrobial peptide therapeutics for cystic fibrosis.

Authors:  Lijuan Zhang; Jody Parente; Scott M Harris; Donald E Woods; Robert E W Hancock; Timothy J Falla
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

10.  Temporins, small antimicrobial peptides with leishmanicidal activity.

Authors:  Maria Luisa Mangoni; José M Saugar; Maria Dellisanti; Donatella Barra; Maurizio Simmaco; Luis Rivas
Journal:  J Biol Chem       Date:  2004-10-28       Impact factor: 5.157

View more
  21 in total

1.  Host Cell Interactions Are a Significant Barrier to the Clinical Utility of Peptide Antibiotics.

Authors:  Charles G Starr; Jing He; William C Wimley
Journal:  ACS Chem Biol       Date:  2016-11-07       Impact factor: 5.100

2.  Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.

Authors:  Vera Lúcia Dias Siqueira; Rosilene Fressatti Cardoso; Katiany Rizzieri Caleffi-Ferracioli; Regiane Bertin de Lima Scodro; Maria Aparecida Fernandez; Adriana Fiorini; Tania Ueda-Nakamura; Benedito Prado Dias-Filho; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 3.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo.

Authors:  Daniela Uccelletti; Elena Zanni; Ludovica Marcellini; Claudio Palleschi; Donatella Barra; Maria Luisa Mangoni
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

5.  Membrane interaction and antibacterial properties of two mildly cationic peptide diastereomers, bombinins H2 and H4, isolated from Bombina skin.

Authors:  Cristina Coccia; Andrea C Rinaldi; Vincenzo Luca; Donatella Barra; Argante Bozzi; Antonio Di Giulio; Enno C I Veerman; Maria Luisa Mangoni
Journal:  Eur Biophys J       Date:  2011-02-17       Impact factor: 1.733

6.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

7.  The Remarkable Innate Resistance of Burkholderia bacteria to Cationic Antimicrobial Peptides: Insights into the Mechanism of AMP Resistance.

Authors:  Jenisha Ghimire; Shantanu Guha; Benjamin J Nelson; Lisa A Morici; William C Wimley
Journal:  J Membr Biol       Date:  2022-04-18       Impact factor: 2.426

Review 8.  The chemical and evolutionary ecology of tetrodotoxin (TTX) toxicity in terrestrial vertebrates.

Authors:  Charles T Hanifin
Journal:  Mar Drugs       Date:  2010-03-10       Impact factor: 5.118

9.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

10.  Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis.

Authors:  Anna M Piras; Giuseppantonio Maisetta; Stefania Sandreschi; Matteo Gazzarri; Cristina Bartoli; Lucia Grassi; Semih Esin; Federica Chiellini; Giovanna Batoni
Journal:  Front Microbiol       Date:  2015-04-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.